CEROW
CERO THERAPEUTICS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−34.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
223.6%
Return on equity
-938.7%
Return on assets
212.0%
Return on invested capital
0.00x
Asset turnover
-$14.4M
Cash from operations
$0.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026